Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations

被引：0
|
作者：
Mueller, Martin C. [1 ]
Cortes, Jorge [2 ]
Kim, Dong-Wook [3 ]
Druker, Brian J. [4 ]
Erben, Philipp [1 ]
Pasquini, Ricardo [5 ]
Hughes, Timothy P. [6 ]
Matloub, Yousif [7 ]
Ploughman, Lynn [7 ]
Hochhaus, Andreas [1 ]
机构：
[1] Univ Heidelberg, Med Fak Mannheim, D-6800 Mannheim, Germany
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] St Marys Hosp, Div Hematol, Seoul, South Korea
[4] Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA
[5] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
[6] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[7] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [1] Nilotinib Efficacy According to Baseline BCR-ABL Mutations in Patients with Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Hochhaus, Andreas
    Kim, Dong-Wook
    Martinelli, Giovanni
    Hughes, Timothy P.
    Soverini, Simona
    Branford, Susan
    Muller, Martin C.
    Erben, Philipp
    Haque, Ariful
    Shou, Yaping
    Saglio, Giuseppe
    Radich, Jerald P.
    BLOOD, 2008, 112 (11) : 1103 - 1104
  • [2] DASATINIB EFFICACY AFTER IMATINIB FAILURE BY DOSING SCHEDULE AND BASELINE BCR-ABL MUTATION STATUS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
    Hochhaus, A.
    Mueller, M. C.
    Cortes, J.
    Kim, D. W.
    Matloub, Y.
    Ploughman, L.
    Hughes, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 371 - 372
  • [3] RESPONSE TO NILOTINIB IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN CHRONIC PHASE (CML-CP) ACCORDING TO BCR-ABL MUTATIONS AT BASELINE
    Radich, J.
    Kim, D. -W
    Martinelli, G.
    Soverini, S.
    Branford, S.
    Mueller, M.
    Haque, A.
    Shou, Y.
    Hochhaus, A.
    Hughes, T.
    Saglio, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 55 - 55
  • [4] Dasatinib efficacy by dosing schedule across individual baseline BCR-ABL mutations in chronic phase chronic myelogenous leukemia (CML-CP) after imatinib failure
    Hochhaus, A.
    Mueller, M.
    Cortes, J. E.
    Kim, D.
    Matlob, Y.
    Ploughman, L.
    Hughes, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Prediction for Sustained Deep Molecular Response of BCR-ABL Levels in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2016, 128 (22)
  • [6] Response to nilotinib in chronic myelogenous leukemia patients in chronic phase (CML-CP) according to BCR-ABL mutations at baseline #7060
    Saglio, G.
    Radich, J.
    Kim, D.
    Martinelli, G.
    Branford, S.
    Mueller, M.
    Soverini, S.
    Shou, Y.
    Hochhaus, A.
    Hughes, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Resistance, Outcome and the Development of Mutations with Dasatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP).
    Shah, Neil
    Bahceci, Erkut
    Lambert, Alexandre
    Ploughman, Lynn
    Radich, Jerald
    BLOOD, 2009, 114 (22) : 460 - 460
  • [8] Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
    Al-Ameri, Ali
    Kantarjian, Hagop
    Borthakur, Gautam
    Bahceci, Erkut
    Szatrowski, Ted
    Damokosh, Andrew
    Cortes, Jorge
    BLOOD, 2009, 114 (22) : 459 - 459
  • [9] Molecular Responses to Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Michor, Franziska
    Olshen, Adam
    Gonen, Mithat
    Jones, Dan
    Rios, Mary Beth
    O'Brien, Susan
    Cortes, Jorge
    BLOOD, 2008, 112 (11) : 1114 - 1115
  • [10] BCR-ABL Fluctuation Analysis in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients with MR 4.5
    Pereira, Mariana Pinto
    Vanelli, Tito
    da Silva, Eduardo Gomes
    Americo, Andre Dias
    Burin, Mariana M.
    Soares, Tahiane
    Silla, Lucia
    Daudt, Liane
    Fogliatto, Laura
    BLOOD, 2015, 126 (23)
12345